insights_auto
Why is DHER34 up 2.70%?
Dive Deeperchevron_right
DHER34:BVMF
Danaher Corporation Bdr
R$ 40.72
arrow_upward
+2.70%(+1.07) 1D
9-р сарын 30, 16:56:00 (GMT-3) · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DHER34...
Open
R$ 41.12
High
R$ 41.12
Low
R$ 40.72
Mkt. cap
155.75Т
Avg. vol.
2.96 мян
Volume
528.00
52-wk high
R$ 45.87
52-wk low
R$ 27.94
Shares outstanding
702.99 сая
No. of employees
59 мян
Open
R$ 41.12
High
R$ 41.12
Low
R$ 40.72
Mkt. cap
155.75Т
Avg. vol.
2.96 мян
Volume
528.00
52-wk high
R$ 45.87
52-wk low
R$ 27.94
Shares outstanding
702.99 сая
No. of employees
59 мян
News stories
From web sources and news partners
Investing.com Canada
·
34 минутын өмнө
Danaher names Julie Sawyer Montgomery as president and CEO By Investing.com
Pluang
·
48 минутын өмнө
Danaher names Julie Sawyer Montgomery as new CE...
Barchart.com
·
1 цагийн өмнө
What You Need to Know Ahead of Danaher’s Earnings Release
Stock Titan
·
1 цагийн өмнө
Danaher's new CEO joins its board as Rainer Blair advises through March.
Profile
Danaher Corporation is an American healthcare company headquartered in Washington, D.C.. It develops products used for advances in biotechnology, life sciences, and diagnostics. The company operates three divisions: biotechnology, which develops products for the development of therapeutics; life sciences, which develops products to identify causes of disease, new therapies, and to test and manufacture new drugs, vaccines and gene editing technologies; and diagnostics, which develops instruments, consumables, and software and services to diagnose diseases. Danaher was founded in 1984 by brothers Steven Rales and Mitchell Rales; it was named after Danaher Creek in Western Montana, where the brothers came up with the idea for the company while fishing.
The company is ranked 180th on the Fortune 500 and 241st on the Forbes Global 2000. Wikipedia
About Danaher Corporation Bdr